Renee Breed

Renee Breed is Vice President of Medical Safety Operations at Vincerx and brings 20 years of pharmacovigilance experience in oncology product development. Before joining Vincerx, Ms. Breed was head of Medical Safety Operations and Excellence at Acerta Pharma (AstraZeneca), head of Drug Safety Operations at Onyx (Amgen), head of Pharmacovigilance at Sunesis, and head of Drug Safety Risk Management Operations at InterMune (Roche). Ms. Breed’sexperience has focused on early to late-phase assets in hematologic malignancies, including leading safety activities for the product launch of Kyprolis® (carfilzomib) for multiple myeloma and CALQUENCE® (acalabrutinib) for mantle cell lymphoma and chronic lymphocytic leukemia. Her background is supplemented with product development in solid tumor, pulmonary, hepatic, and infectious disease indications.

Ms. Breed holds a Bachelor of Science in Biology from the University of Wisconsin in Madison.